Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
11,879
datasets available to search
ShareScore release 0.9.0
Dataset results
11,879 results for “participation”
A Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01178086. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of LY900014 Formulation at Different Injection Sites in Healthy Participants
ClinicalTrials.gov study NCT03232983. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy Participants
ClinicalTrials.gov study NCT05644353. IPD Sharing: NO. Countries: 1. Publications: 1.
First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.
ClinicalTrials.gov study NCT04535167. IPD Sharing: NO. Countries: 4. Publications: 2.
A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT02079636. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis
ClinicalTrials.gov study NCT02757352. IPD Sharing: YES. Countries: 16. Publications: 10.
Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma
ClinicalTrials.gov study NCT01454076. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study in Participants With End-Stage Renal Disease
ClinicalTrials.gov study NCT01200290. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Participants
ClinicalTrials.gov study NCT01290679. IPD Sharing: Not stated. Countries: 15. Publications: 2.
A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors
ClinicalTrials.gov study NCT03854227. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC)
ClinicalTrials.gov study NCT01926886. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).
ClinicalTrials.gov study NCT02670083. IPD Sharing: Not stated. Countries: 30. Publications: 4.
A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments
ClinicalTrials.gov study NCT04418765. IPD Sharing: YES. Countries: 17. Publications: 10.
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
ClinicalTrials.gov study NCT02417064. IPD Sharing: Not stated. Countries: 9. Publications: 12.
Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metasta
ClinicalTrials.gov study NCT03036098. IPD Sharing: Not stated. Countries: 30. Publications: 2.
A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer
ClinicalTrials.gov study NCT04739761. IPD Sharing: YES. Countries: 18. Publications: 1.
Health Literacy Intervention for Informed Consent of Cancer Patients Considering Clinical Trial Participation
ClinicalTrials.gov study NCT01964222. IPD Sharing: Not stated. Countries: 1. Publications: 19.
Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis B
ClinicalTrials.gov study NCT03491553. IPD Sharing: NO. Countries: 2. Publications: 1.
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
ClinicalTrials.gov study NCT02219932. IPD Sharing: Not stated. Countries: 11. Publications: 1.
A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program
ClinicalTrials.gov study NCT04657016. IPD Sharing: YES. Countries: 4. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.